Home > News
2018-10President Ae-June Wang received the Excellence in Management Award at the 7th Woman Elite Entrepreneurs Competition.
2018-06Andros Pharmaceuticals received Taiwan FDA licenses for 2% and 5% iMinos Solution (site change)
2018-02Andros Pharmaceuticals passed TFDA audit inspection of GMP and GDP.
2017-04Andros Pharmaceuticals received Taiwan FDA license for LALP Cream (site change)
2016-12Andros Pharmaceuticals received innovative product award from Hsinchu Science Park on December 2016
2016-10The Commercial Times reported Andros won the award of SBIR program
2016-10Andros Pharmaceuticals won the excellent execution award of SBIR program on October 2016
2016-03Andros Pharmaceuticals got the certificate of PIC/S GMP for adding liquid dosage form.
2015-09Andros Pharmaceuticals got the certificate of PIC/S GMP.
2015-03Complete the fifth round financing in March 2015. The capital increased to NTD 243M.
2015-02Complete the forth round financing in February 2015. The capital increased to NTD 213M.
2014-07"The preclinical study of the topical anesthetic new dosage form" project has received the SBIR grant from MOEA.
2014-05"The subsequent project of topical delivery system development" received R&D subsidy from Taipei city government.
2014-02The Commercial Times reported the recent development of Andros Pharmaceuticals and praised our performance.
2013-12Andros Pharmaceuticals is recognized by Ministry of Economic Affairs as a “Biotech and New Pharmaceuticals Company”.
2013-07Complete the third round financing in July 2013. The capital increased to NTD 150M.
2013-06The newest job opportunities are available now
2013-02"The development of topical delivery system" project received research and development subsidy from Taipei city government.
2013-01The Commercial Times reported Andros Pharmaceuticals entered Hsinchu Biomedical Science Park.
2013-01Andros Pharmaceuticals has relocated to Hsinchu Biomedical Science Park on 2nd Jan, 2013.
2012-10Complete the second round of financing in October 2012. The capital increased to NTD 100M.
2011-06Received NTD 12M of SBIR grant from MOEA for the development of “topical anesthetic new dosage form” project.
2011-05Opening of the Hsinchu biomedical science park research building attended by President Ma Ying-Jeou.
2010-11Approved by Hsinchu biomedical science park for relocation in late-2012.